Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects

Neuron

Volumn 43, Issue 4, 2004, Pages 487-497

  Xu, Yan Ling ^a   Reinscheid, Rainer K ^a   Huitron Resendiz, Salvador ^c   Clark, Stewart D ^a   Wang, Zhiwei ^a   Lin, Steven H ^a   Brucher, Fernando A ^b   Zeng, Joanne ^a   Ly, Nga K ^a   Henriksen, Steven J ^c   De Lecea, Luis ^c   Civelli, Olivier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE S; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; AROUSAL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LOCOMOTION; LOCUS CERULEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REM SLEEP; STRESS; THALAMUS NUCLEUS; TRANQUILIZING ACTIVITY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AROUSAL; BRAIN; CHO CELLS; CONSERVED SEQUENCE; CRICETINAE; EVOLUTION, MOLECULAR; FEMALE; HUMANS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 4143111307     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2004.08.005     Document Type: Article

References (49)

1. Aston-Jones G., Chiang C., Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res. 88:1991;501-520. a
2. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., van Bockstaele E., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B., et al. Afferent regulation of locus coeruleus neurons. anatomy, physiology and pharmacology Prog. Brain Res. 88:1991;47-75. b
3. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system. modulation of behavioral state and state-dependent cognitive processes Brain Res. Brain Res. Rev. 42:2003;33-84
4. Bing O., Moller C., Engel J.A., Soderpalm B., Heilig M. Anxiolytic-like action of centrally administered galanin. Neurosci. Lett. 164:1993;17-20
5. Borsini F., Podhorna J., Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl.). 163:2002;121-141
6. Bourgin P., Huitron-Resendiz S., Spier A.D., Fabre V., Morte B., Criado J.R., Sutcliffe J.G., Henriksen S.J., de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20:2000;7760-7765
7. Chaouloff F., Durand M., Mormede P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav. Brain Res. 85:1997;27-35
8. Charney D.S., Deutch A. A functional neuroanatomy of anxiety and fear. implications for the pathophysiology and treatment of anxiety disorders Crit. Rev. Neurobiol. 10:1996;419-446
9. Chojnacka-Wojcik E., Klodzinska A., Pilc A. Glutamate receptor ligands as anxiolytics. Curr. Opin. Investig. Drugs. 2:2001;1112-1119
10. Cirelli C., Pompeiano M., Tononi G. Neuronal gene expression in the waking state. a role for the locus coeruleus Science. 274:1996;1211-1215
11. Civelli O., Nothacker H.P., Saito Y., Wang Z., Lin S.H., Reinscheid R.K. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci. 24:2001;230-237
12. Clark S.D., Nothacker H.P., Wang Z., Saito Y., Leslie F.M., Civelli O. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res. 923:2001;120-127
13. Foote S.L., Aston-Jones G., Bloom F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. USA. 77:1980;3033-3037
14. Gottesmann C. GABA mechanisms and sleep. Neuroscience. 111:2002;231-239
15. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA. 96:1999;10911-10916
16. Hascoet M., Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol. Biochem. Behav. 60:1998;645-653
17. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation. reciprocal discharge by two brainstem neuronal groups Science. 189:1975;55-58
18. Holmes A., Kinney J.W., Wrenn C.C., Li Q., Yang R.J., Ma L., Vishwanath J., Saavedra M.C., Innerfield C.E., Jacoby A.S., et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology. 28:2003;1031-1044
19. Hunsley M.S., Palmiter R.D. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep. 26:2003;521-526
20. Jones B.E. The role of noradrenergic locus coeruleus neurons and neighboring cholinergic neurons of the pontomesencephalic tegmentum in sleep-wake states. Prog. Brain Res. 88:1991;533-543
21. Jones B.E. Arousal systems. Front. Biosci. 8:2003;s438-s451
22. Köster A., Montkowski A., Schulz S., Stübe E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. USA. 96:1999;10444-10449
23. Laitinen T., Polvi A., Rydman P., Vendelin J., Pulkkinen V., Salmikangas P., Makela S., Rehn M., Pirskanen A., Rautanen A., et al. Characterization of a common susceptibility locus for asthma-related traits. Science. 304:2004;300-304
24. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods. 16:1986;355-357
25. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70:2003;83-244
26. Njung'e K., Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 38:1991;63-67
27. Ohayon M.M., Caulet M., Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr. Psychiatry. 39:1998;185-197
28. Paine T.A., Jackman S.L., Olmstead M.C. Cocaine-induced anxiety. alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine Behav. Pharmacol. 13:2002;511-523
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates, Compact. Third Edition:1997;Academic Press, San Diego
30. Redmond D.E. Jr., Huang Y.H. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci. 25:1979;2149-2162
31. Reinscheid R.K., Civelli O. The orphanin FQ/nociceptin knockout mouse. a behavioral model for stress responses Neuropeptides. 36:2002;72-76
32. Rizvi T.A., Ennis M., Aston-Jones G., Jiang M., Liu W.L., Behbehani M.M., Shipley M.T. Preoptic projections to Barrington's nucleus and the pericoerulear region. architecture and terminal organization J. Comp. Neurol. 347:1994;1-24
33. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303
34. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex. anatomy and physiology Physiol. Rev. 83:2003;803-834
35. Saito Y., Nothacker H.P., Wang Z., Lin S.H., Leslie F., Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature. 400:1999;265-269
36. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., et al. Orexins and orexin receptors. a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell. 92:1998;573-585
37. Saper C.B., Chou T.C., Scammell T.E. The sleep switch. hypothalamic control of sleep and wakefulness Trends Neurosci. 24:2001;726-731
38. Sato, S., Shintani, Y., Miyajima, N., and Yoshimura, K. (2002). Novel G protein-coupled receptor protein and DNA thereof. World Patent Application. WO 02/31145 A1.
39. Shimomura Y., Harada M., Goto M., Sugo T., Matsumoto Y., Abe M., Watanabe T., Asami T., Kitada C., Mori M., et al. Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8. J. Biol. Chem. 277:2002;35826-35832
40. Silva A.P., Cavadas C., Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin. Chim. Acta. 326:2002;3-25
41. Sutcliffe J.G., de Lecea L. The hypocretins. setting the arousal threshold Nat. Rev. Neurosci. 3:2002;339-349
42. Sutin E.L., Jacobowitz D.M. Immunocytochemical localization of peptides and other neurochemicals in the rat laterodorsal tegmental nucleus and adjacent area. J. Comp. Neurol. 270:1988;243-270
43. Swanson L.W., Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163:1975;467-505
44. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain. an immunohistochemical study Neuroendocrinology. 36:1983;165-186
45. Ursin R. Serotonin and sleep. Sleep Med. Rev. 6:2002;55-69
46. Valentino R.J., Pavcovich L.A., Hirata H. Evidence for corticotropin-releasing hormone projections from Barrington's nucleus to the periaqueductal gray and dorsal motor nucleus of the vagus in the rat. J. Comp. Neurol. 363:1995;402-422
47. Valentino R.J., Kosboth M., Colflesh M., Miselis R.R. Transneuronal labeling from the rat distal colon. anatomic evidence for regulation of distal colon function by a pontine corticotropin-releasing factor system J. Comp. Neurol. 417:2000;399-414
48. Van der Werf Y.D., Witter M.P., Groenewegen H.J. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res. Brain Res. Rev. 39:2002;107-140
49. Wilson S., Bergsma D.J., Chambers J.K., Muir A.I., Fantom K.G., Ellis C., Murdock P.R., Herrity N.C., Stadel J.M. Orphan G-protein-coupled receptors. the next generation of drug targets? Br. J. Pharmacol. 125:1998;1387-1392